Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Healthcare

ImmunoScape takes in $14m sight
UTEC has returned to co-lead a $14m funding round for ImmunoScape, which will use the money to bolster its presence in Singapore and the US.
Daily deal net: April 14, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Vizgen visualises $37m series B
Vizgen co-founder David Walt, a professor at Harvard Medical School, has invested in the spinout as part of its series B round.
Carta Healthcare carves out series A funding
CU Health Innovation Fund has chipped into a $17.3m round for the healthcare data technology provider.
Daily deal net: April 12, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Schroders shifts Carrick stake at discount
Schroder UK Public Private Trust, the rebranded fund previously led by Neil Woodford, has sold its shareholding in Carrick Therapeutics at a discount.
Oxford Endovascular enters series A stage
University of Oxford, OSI and Parkwalk Advisors all returned for Oxford Endovascular’s $10m series A round.
Vaccitech shoots for US IPO
Oxford spinout Vaccitech, which developed the technology underlying the university’s covid vaccine, has filed for an offering on the Nasdaq Global Market.

Other News

Daily deal net: April 9, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Ventus Therapeutics executes $100m series B
RA Capital has led a $100m series B round for Ventus Therapeutics, which is linked to multiple universities.
Metagenomi magnifies series A to $75m
UC Berkeley's DNA-editing technology spinout has raised $10m from RA Capital in addition to the $65m it pocketed in November.
Icosavax racks up $100m
RA Capital Management has led a series B round for the UW-linked vaccine developer, which had raised $51m in a series A 18 months ago.
Daily deal net: April 6, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Fraunhofer forms 26 spinouts in 2020
Fraunhofer Society has found minimal impact from lockdowns and the pandemic on the number of spinouts its institutes were able to generate last year.

Editor's Picks

When worlds collide – CVC interest in spinouts
Steady is the assessment that comes to mind, rather than remarkable, when probing the year-on-year direction of corporate venture capital investment in university spinouts.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
test reg

Login